What is the management of pleomorphic adenoma of the parotid gland?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pleomorphic Adenoma of the Parotid Gland

The definitive management of pleomorphic adenoma of the parotid gland is surgical excision with appropriate margins, with the specific surgical approach determined by tumor location and characteristics. 1

Surgical Approach Based on Tumor Characteristics

The surgical approach should be tailored according to the following parameters:

  • For superficial lobe tumors (most common - 81.7% of cases) 2:

    • T1 or T2 low-grade: Partial superficial parotidectomy
    • Larger tumors: Superficial (exofacial) parotidectomy
  • For deep lobe tumors:

    • Total parotidectomy is recommended 2
  • For recurrent disease:

    • Revision surgery with consideration of total parotidectomy and neck dissection 1
    • Previous scar should be excised during the procedure 3

Surgical Technique Considerations

  1. Facial nerve preservation:

    • Preservation should be performed when preoperative function is intact
    • Create a dissection plane between tumor and nerve
    • Facial nerve branch resection only when preoperative movement is impaired or branches are encased by confirmed malignancy 1
  2. Capsule integrity:

    • Complete excision without perforation of the capsule/pseudocapsule is crucial
    • Avoid dissection near the tumor capsule, which is the major cause of recurrence 3
    • "En-bloc" resection technique is preferred 4
  3. Intraoperative considerations:

    • Intraoperative pathologic examination may guide extent of resection
    • Frozen section accuracy: 99% for identifying neoplastic lesions 1
    • Meticulous hemostasis and layered wound closure are essential 1
    • Maintaining thick skin flaps when oncologically appropriate reduces complications 1

Outcomes and Complications

Recurrence Rates

  • Very low (0.8%) with appropriate surgical technique 1
  • Higher risk factors for recurrence:
    • Previous incomplete surgery
    • Positive margins
    • Capsule infiltration 2

Facial Nerve Function

  • Temporary facial weakness: approximately 27% of cases
  • Permanent facial weakness: 2.5% of patients with normal preoperative function 1
  • Transitory facial paralysis is higher after total parotidectomy compared to superficial procedures 2

Other Complications

  • Frey syndrome (gustatory sweating)
  • Greater auricular nerve anesthesia
  • Hematoma formation
  • Salivary fistula 1
  • Depression or swelling at the surgical site 5

Post-Surgical Management

  • Regular follow-up is essential as recurrences can develop years after surgery 1
  • For recurrent cases, particularly those extending into the parapharyngeal space, postoperative radiotherapy may be considered 6
  • Patient education about potential delayed onset of symptoms is important 1

Surgical Approach Comparison

Research comparing superficial parotidectomy (SP) with retrograde partial superficial parotidectomy (PSP) found:

  • PSP had shorter surgical time (145 vs 171 minutes)
  • PSP preserved more healthy parotid tissue
  • PSP had significantly fewer facial nerve injuries (10% vs 61%)
  • However, Frey syndrome was more common with PSP 5

Special Considerations

  • For tumors extending into the parapharyngeal space, combined surgical approaches may be necessary (e.g., cervical-transparotid and mandibular swing approach) 6
  • MRI is crucial for assessing tumor extent, particularly for deep lobe involvement or parapharyngeal extension 6
  • The close proximity of vital neurovascular structures requires careful preoperative evaluation 6

References

Guideline

Management of Salivary Gland Tumors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Surgery of pleomorphic adenoma of the parotid gland].

Revue de stomatologie, de chirurgie maxillo-faciale et de chirurgie orale, 2015

Research

Superficial parotidectomy versus retrograde partial superficial parotidectomy in treating benign salivary gland tumor (pleomorphic adenoma).

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.